Skip to content

Identifying Risk Factors and Predicting Future Health Outcomes for Korean Patients With Heart and Blood Vessel Diseases: A Long-term Follow-up Study

PRIME (Precision Registry for Integrated Cardio-cerebrovascular Medicine & Evidence)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07393412
Enrollment
800000
Registered
2026-02-06
Start date
2026-02-02
Completion date
2040-12-31
Last updated
2026-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Diseases (CVD), Cerebro Vascular Disease

Brief summary

This study aims to establish a comprehensive, long-term clinical registry infrastructure for heart and brain vascular diseases (cardiovascular diseases and stroke) at Samsung Medical Center. In South Korea, these diseases are a leading cause of death, with a rapidly increasing burden due to an aging population and changing lifestyles. Despite this, there is a lack of large-scale, systematic data specifically focused on the long-term clinical course and unique characteristics of Korean patients. The central hypothesis of this study is that the establishment of a standardized registry infrastructure-integrating both retrospective (historical) and prospective (future) data collection-will provide a more accurate and comprehensive understanding of the natural history and risk factors of heart and brain vascular diseases in the Korean population than currently available fragmented data. By combining existing medical records with ongoing patient follow-up, this infrastructure will serve as a critical scientific platform for developing personalized prevention and precision medicine strategies. By building this organized data collection system, the study will: Construct a robust infrastructure to collect uniform, high-quality clinical data, encompassing both past medical history (retrospective) and future clinical progress (prospective) from a large population of Korean patients. Monitor long-term health outcomes and the progression of diseases by tracking patients over many years. Analyze the interaction between various risk factors and patient outcomes to identify population-specific patterns. Create a scalable platform that can integrate advanced technologies, such as multi-omics and digital health tools, for future research. Ultimately, this integrated registry infrastructure is expected to provide the essential scientific evidence needed to optimize clinical guidelines and improve the long-term quality of life for patients with heart and brain vascular diseases in Korea.

Interventions

DRUGStandard Medical Therapy

Routine pharmacological treatments including antiplatelets, antihypertensives

PROCEDURERevascularization Procedures

Surgical or interventional procedures such as PCI (Percutaneous Coronary Intervention) or stent thrombectomy for stroke.

BEHAVIORALLifestyle Modification

Habitual factors including smoking cessation, physical activity, and dietary habits monitored during the follow-up.

Sponsors

Samsung Medical Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

A patient who visited Samsung Medical Center due to cardiovascular and cerebrovascular disease.

Exclusion criteria

A patient deemed unable to participate in the study based on the judgment of the medical staff.

Design outcomes

Primary

MeasureTime frame
Incidence of Major Adverse Cardio-Cerebrovascular Events (MACCE)Up to 20 years (from the date of enrollment until the end of the follow-up period)

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 29, 2026